Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (811-820 of 1,115) with videos related to

Pageof 112
Sort By:
Blood|December 1, 1985
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalH M Kantarjian, T L Smith, K B McCredie, et al.
Biodata Mining|February 3, 2023
LoFTK: a framework for fully automated calculation of predicted Loss-of-Function variants and genesAbdulrahman Alasiri, Konrad J Karczewski, Brian Cole, et al.
Cancer|November 1, 1986
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Cancer|May 13, 2008
Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicityAmar Safdar, Gilhen H Rodriguez, Adriana M Rueda, et al.
Blood|January 25, 2008
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesMichael Hallek, Bruce D Cheson, Daniel Catovsky, et al.
Blood|March 26, 2009
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approachMatthias Niedermeier, Bryan T Hennessy, Zachary A Knight, et al.
Blood|April 30, 2010
Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemiaKumudha Balakrishnan, Dushyant Verma, Susan O'Brien, et al.
Blood|October 5, 2014
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)Constantine S Tam, Susan O'Brien, William Plunkett, et al.
Molecular Cancer Research : MCR|August 25, 2017
B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic LeukemiaHima V Vangapandu, Ondrej Havranek, Mary L Ayres, et al.
Leukemia & Lymphoma|November 9, 2001
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survivalF J Giles, Y Shen, H M Kantarjian, et al.
Pageof 112

Showing results (811-820 of 1,115) with videos related to

Sort By:
Pageof 112
Blood|December 1, 1985
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalH M Kantarjian, T L Smith, K B McCredie, et al.
Biodata Mining|February 3, 2023
LoFTK: a framework for fully automated calculation of predicted Loss-of-Function variants and genesAbdulrahman Alasiri, Konrad J Karczewski, Brian Cole, et al.
Cancer|November 1, 1986
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Cancer|May 13, 2008
Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicityAmar Safdar, Gilhen H Rodriguez, Adriana M Rueda, et al.
Blood|January 25, 2008
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesMichael Hallek, Bruce D Cheson, Daniel Catovsky, et al.
Blood|March 26, 2009
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approachMatthias Niedermeier, Bryan T Hennessy, Zachary A Knight, et al.
Blood|April 30, 2010
Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemiaKumudha Balakrishnan, Dushyant Verma, Susan O'Brien, et al.
Blood|October 5, 2014
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)Constantine S Tam, Susan O'Brien, William Plunkett, et al.
Molecular Cancer Research : MCR|August 25, 2017
B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic LeukemiaHima V Vangapandu, Ondrej Havranek, Mary L Ayres, et al.
Leukemia & Lymphoma|November 9, 2001
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survivalF J Giles, Y Shen, H M Kantarjian, et al.
Pageof 112